Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2006-02-07
2006-02-07
Hayes, Robert C. (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S006120
Reexamination Certificate
active
06994974
ABSTRACT:
The present invention provides an isolated nucleic acid encoding an endoplasmic reticulum associated amyloid-beta peptide binding (ERAB) polypeptide. The ERAB polypeptide may comprise human ERAB polypeptide. The present invention provides a purified ERAB polypeptide, as well as a method for treating a neurodegenerative condition in a subject which comprises administering to the subject an agent in amount effective to inhibit ERAB polypeptide binding to amyloid-beta peptide so as to thereby treat the neurodegenerative condition.
REFERENCES:
patent: WO 9403599 (1994-02-01), None
Rudinger, In “Peptide Hormones” (ed. J.A. Parens) University Park Press Baltimore, pp. 1-7, 1976.
Borchelt, D. R. et al. (1996) “Familial Alzheimer's Disease-Linked Presenilin 1 Variants Elevate Ab1-42/1-40 Ratio In Vitro and In Vivo.”Neuron, 17: 1005-1013.
Burke, J. R. et al. (1996) “Huntingtin and DRPLA Proteins Selectively Interact with the Enzyme GAPDH.”Nature Medicine, 2 (3) : 347-350.
Cai, X-D. et al. (1993) “Release of Excess Amyloid b Protein from a Mutant Amyloid b Protein Precursor.”Science, 253: 514-516.
Citron, M. et al. (1997) “Mutant Presenilins of Alzheimer's Disease Increase Production of 42-Residue Amyloid b-Protein in both Transfected Cells and Transgenic Mice.”Nature Medicine, 3 (1) : 67-72.
Huo, Y-M. et al. (1996) “Water-soluble Ab (N-40, N-42) Oligomers in Normal and Alzheimer Disease Brains.”J. Biol. Chem.,171 (8) : 4077-4081.
Fuwabara, K. et al. (1996) “Purification and Characterization of a Novel Stress Protein, the 150-kDa Oxygen-regulated Protein (ORP 150), from Cultured Fat Astrocytes and Its Expression in Ischemic Mouse Brain.”J. Biol. Chem.,171 (9) : 5025-5032.
Paresce, D. M. et al. (1996) “Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid b-Protein Via a Scavenger Receptor.”Neuron, 17: 553-565.
Roher, A. E. et al. (1996) “Morphology and Toxicity of Ab- (1-42) Dimer Derived from Neuritic and Vascular Amyloid Deposits of Alzheimer's Disease.”J. Biol. Chem.,.71 (34) : 20631-20635.
Scheuner, D. et al. (1996) “Secreted Amyloid b-Protein Similar to that in the Senile Plaques of Alzheimer's Disease is Increased in vivo by the Presenilin 1 and 2 and APP Mutations Linked to Familial Alzheimer's Disease.”Nature Medicine, 2 (8) : 864-870.
Turner, R. S. et al. (1997) “Amyloids b40 and b 42 Are Generated Intracellularly in Cultured Human Neurons and Their Secretion Increases with Maturation.”J. Biol. Chem.,271 (15) : 8966-8970.
Wild-Bode, C. et al. (1997) “Intracellular Generation and Accumulation of Amyloid b-Peptide Terminating at Amino Acid 42.”J. Biol. Chem.,268 (26) : 16085-16088.
Wolozin, W. et al. (1996) “Participation of Presenilin 2 in Apoptosis: Enhanced Basal Activity Conferred by an Alzheimer Mutation.”Science, 247: 1710-1713.
Xia, W. et al. (1997) “Enhanced Production and Oligomerization of the 43-Residue Amyloid b-Protein by Chinese Hamster Ovary Cells Stably Expressing Mutant Presenilins.”J. Biol. Chem.,172 (12) : 7977-7982.
Yan, S. D. et al. (1994) “Glycated Tau Protein in Alzheimer Disease: A Mechanism for Induction of Oxidant stress.”Proc. Natl. Acad. Sci. USA, P1 7787-7791.
Yan, S. D. et al. (1995) “Non-enzymatically Glycated Tau in Alzheimer's Disease Induces Neuronal Oxidant Stress Resulting in Cytokine Gene Expression and Release of Amyloid b-Peptide.”Nature Medicine, . (7) : 693-699.
Yan, S. D. et al. (1996) “RAGE and Amyloid-b Peptide Neurotoxicity in Alzheimer's Disease.”Nature, 382: 685-691.
Yankner, B. A. et al. (1990) “Neurotrophic and Neurotoxic Effects of Amyloid b-Protein: Reversal by Tachykinin Neuropeptides.”Science, 250: 279-282.
Adams et al. Initial Assessment of Human Gene Diversity and Expression and Patterns Based Upon 83 Million Nucleotides of cDNA Sequence. Nature. Sep. 23, 1995, vol. 377, No. 6547 supplement, pp. 3-17.
Furuta et al. Cloning and Expression of cDNA for a Newly Identified Isozyme of Bovine liver 3-Hydroxyacyl-CoA Dehydrognease and its Import into Mitochondria. Biochimica et Biophysica Acta. Feb. 28, 1997, vol. 1350, pp. 317-324.
Yan et al. An Intracellular Protein that Binds Amyloid-β Peptide and Mediates Neurotoxicity in Alzheimer's Disease. Nature. Oct. 16, 1997, vol. 389, pp. 689-695, see entire document.
Stern David M.
Yan Shi Du
Cooper & Dunham LLP
The Trustees Of Columbia University In The City Of New York
White, Esq. John P.
LandOfFree
Intracellular amyloid-beta binding (ERAB)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular amyloid-beta binding (ERAB)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular amyloid-beta binding (ERAB)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3707575